ReviewThe American journal of pathology1999
Tumor plasticity allows vasculogenic mimicry, a novel form of angiogenic switch. A rose by any other name?
Review in The American journal of pathology, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
40 citing papers in PubMed.
- LIFU/MMP-2 dual-responsive release of repurposed drug disulfiram from nanodroplets for inhibiting vasculogenic mimicry and lung metastasis in triple-negative breast cancer.Journal of nanobiotechnology · 2024Article
- Review
- Non-coding RNAs and glioblastoma: Insight into their roles in metastasis.Molecular therapy oncolytics · 2022Review
- Expression of STAT3 and vasculogenic mimicry in gallbladder carcinoma promotes invasion and metastasis.Experimental and therapeutic medicine · 2021Article
- Transmembrane Protein TMEM230, a Target of Glioblastoma Therapy.Frontiers in cellular neuroscience · 2021Article
- Tissue Engineering of the Microvasculature.Comprehensive Physiology · 2019Review
- Plasticity and Potency of Mammary Stem Cell Subsets During Mammary Gland Development.International journal of molecular sciences · 2019Review
- Fact or Fiction, It Is Time for a Verdict on Vasculogenic Mimicry?Frontiers in oncology · 2019Article
- Functional invadopodia formed in glioblastoma stem cells are important regulators of tumor angiogenesis.Oncotarget · 2018Article
- Future options of anti-angiogenic cancer therapy.Chinese journal of cancer · 2016Article
- Vascular Mimicry: The Next Big Glioblastoma Target.Biochemistry & physiology · 2015Article
- Claudin-4 is required for vasculogenic mimicry formation in human breast cancer cells.Oncotarget · 2015Article
- Merkel cell carcinoma expresses vasculogenic mimicry: demonstration in patients and experimental manipulation in xenografts.Laboratory investigation; a journal of technical methods and pathology · 2014Article
- RANK-mediated signaling network and cancer metastasis.Cancer metastasis reviews · 2014Review
- Brain tumor-targeted drug delivery strategies.Acta pharmaceutica Sinica. B · 2014Review
- [Effects of cetuximab combined with celecoxib on apoptosis and KDR and AQP1 expression in lung cancer].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2013Article
- Hypoxia-induced vasculogenic mimicry formation via VE-cadherin regulation by Bcl-2.Medical oncology (Northwood, London, England) · 2012Article
- Tumor cell vasculogenic mimicry: from controversy to therapeutic promise.The American journal of pathology · 2012Review
- Molecular pathways: vasculogenic mimicry in tumor cells: diagnostic and therapeutic implications.Clinical cancer research : an official journal of the American Association for Cancer Research · 2012Article
- FH535 inhibited migration and growth of breast cancer cells.PloS one · 2012Article
Corrections and comments
- Commented on by
- Comment on
Authors and funding
1 author.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.